Le Lézard
Classified in: Health
Subjects: AWD, TDS

The National Osteoporosis Foundation (NOF) Announces Dr. Robert Gagel as the 2019 Recipient of its Lawrence G. Raisz Memorial Lecture Award

ARLINGTON, Va., May 16, 2019 /PRNewswire/ -- The National Osteoporosis Foundation (NOF) announces Robert Gagel, MD, Professor of Medicine at MD Anderson Cancer Center, Adjunct Professor in the Department of Cell Biology at Baylor College of Medicine and NOF Trustee, as the recipient of its 2019 Lawrence G. Raisz, MD Memorial Lecture Award. Dr. Gagel will present "Bone Health and Osteoporosis in Long-Term Cancer Survivors" at the Interdisciplinary Symposium on Osteoporosis (ISO19), the nation's leading clinical conference on bone health, taking place in La Jolla, California this week from May 15-18.

National Osteoporosis Foundation. (PRNewsFoto/National Osteoporosis Foundation)

With two million fractures caused by osteoporosis each year and 75,000 people a year dying because of osteoporotic-related fractures, ISO19 aims to address the current crisis in osteoporosis by providing the most up-to-date, clinically relevant and evidence-based information on the prevention, diagnosis and treatment of osteoporosis. World-renowned experts in the bone health field will present plenaries and small group sessions on a wide range of topics to provide attendees with many clinical insights and multiple perspectives all intended to improve care for osteoporosis patients and those at risk for fractures.

"We are thrilled to announce Dr. Gagel as the recipient of NOF's highest scientific award, the Lawrence G. Raisz, MD Memorial Lecture Award," said Elizabeth Thompson, CEO, NOF. "As a leading researcher on bone biology and the impact osteoporosis and bone health has on cancer patients, Dr. Gagel has made significant contributions to the osteoporosis and bone metabolism field of study throughout his career."

Dr. Gagel is a renowned medical expert in Multiple Endocrine Neoplasia Type 2 (MEN2) and medullary thyroid carcinoma, as well as bone biology and calcitonin. Dr. Gagel and colleagues developed and validated strategies for early detection of medullary thyroid carcinoma and pheochromocytoma through a 15-year series of articles published in the New England Journal of Medicine. While subsequently pursuing a laboratory fellowship at Harvard Medical School and The Harvard School of Public Health, Dr. Gagel was introduced to bone biology and the physiology of calcitonin, where he has made significant contributions, including studies of the transcriptional regulation of the calcitonin gene, recognition of one of the elements that regulates alternative RNA processing of the calcitonin gene, and most recently the creation of a mouse in which the calcitonin gene has been deleted. 

Dr. Gagel has served in several appointments at the University of Texas MD Anderson Cancer Center, including Professor and Chief of Endocrine Neoplasia and Hormonal Disorders and Chairman of the Department of Medical Specialties. In 2001, he was named Head of the Division of Internal Medicine and served in that role until stepping down in December 2014. In January 2015, he transitioned to the Department of Endocrine Neoplasia and Hormonal Disorders where he has continued his research and patient care. Dr. Gagel also developed and helped establish the Bone Program of Texas, a collaborative program of the Baylor College of Medicine, the University of Texas M.D. Anderson Cancer Center and University of Texas Health Science Center ? Houston, where he currently serves as Director. 

In addition to Dr. Gagel's lecture, ISO19 also offers an introductory and advanced Fracture Liaison Service training and continuing education curriculum, a BoneFittm exercise training workshop on the most appropriate, safe and effective methods to prescribe and progress exercise for people with osteoporosis; and will feature keynote speaker, John Leland, best-selling author and reporter for the New York Times, presenting "Happiness is a Choice You Make."

About the National Osteoporosis Foundation 
Established in 1984, the National Osteoporosis Foundation is the nation's leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.

Contact: Claire Gill


SOURCE National Osteoporosis Foundation

These press releases may also interest you

at 16:47
To support their ongoing efforts to increase accessibility to health care across the Commonwealth, Blue Cross Blue Shield of Massachusetts (Blue Cross) and the City of Boston have announced the expansion of the Bluebikes system to seven new docking...

at 16:37
On September 5, 2019, the BC government announced phase two of its Biosimilars Initiative, informing patients prescribed the originator biologic drug, Remicade® (infliximab), to treat inflammatory bowel disease (Crohn's disease and ulcerative...

at 16:26
Aflac, the leader in supplemental insurance sales at U.S. worksites, today delivered My Special Aflac Ducks to patients at Children's Hospital of Philadelphia. My Special Aflac Duck, designed by Sproutel, is a social robot that uses medical play,...

at 16:25
CureDuchenne, a leading nonprofit in Duchenne research, patient care and innovation, announced today its line-up of CureDuchenne Cares events that will take place across the United States in 2020. CureDuchenne Cares, a division of CureDuchenne, is an...

at 16:22
Brookdale Senior Living Inc. ("Brookdale" or the "Company") today filed its definitive proxy statement with the U.S. Securities and Exchange Commission and is mailing a letter to stockholders in connection with its 2019 Annual Meeting of...

at 16:20
Savara Inc. , an orphan lung disease company, today announced that additional data from IMPALA, an ongoing pivotal Phase 3 clinical study evaluating Molgradex, an inhaled formulation of recombinant human granulocyte-macrophage colony-stimulating...

News published on 16 may 2019 at 18:31 and distributed by: